Literature DB >> 30484907

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017.

Eran Shavit1, Afsaneh Alavi1, Falk G Bechara2, Richard G Bennett3, Marc Bourcier4, Ricardo Cibotti5, Steven Daveluy6, John W Frew7, Amit Garg8, Iltefat Hamzavi9, Lauren K Hoffman10, Jenny Hsaio11, Joslyn Sciacca Kirby12, Hadar Lev-Tov13, Erin Martinez14, Robert Micheletti15, Haley B Naik16, Aude Nassif17, Cynthia Nicholson18, Angie Parks-Miller2,19, Zarine Patel10,20, Vincent Piguet1, Mayur Ramesh21, Barry Resnik13, Christopher Sayed22, Gregory Schultz23, Aamir Siddiqui24, Jerry Tan25, Ximena Wortsman26,27, Michelle A Lowes28.   

Abstract

The 2nd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 03-05 November 2017 in Detroit, Michigan, USA. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF Inc.) founded in the USA, and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This was the second annual meeting of the SHSA with experts from different disciplines arriving from North America, Europe and Australia, in a joint aim to discuss most recent innovations, practical challenges and potential solutions to issues related in the management and care of Hidradenitis Suppurativa patients. The last session involved clinicians, patients and their families in an effort to educate them more about the disease.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hidradenitis suppurativa; symposium

Mesh：

Substances：

Year:  2019        PMID： 30484907      PMCID： PMC6600821          DOI： 10.1111/exd.13849

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN： 0906-6705            Impact factor:   3.960


  36 in total

Review 1.  New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes.

Authors:  Hessel H van der Zee; Gregor B E Jemec
Journal:  J Am Acad Dermatol       Date:  2015-11       Impact factor: 11.527

2.  Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.

Authors:  Zoe D Draelos; Eric Carter; J Michael Maloney; Boni Elewski; Yves Poulin; Charles Lynde; Steven Garrett
Journal:  J Am Acad Dermatol       Date:  2007-01-17       Impact factor: 11.527

3.  Diagnostic delay in hidradenitis suppurativa is a global problem.

Authors:  D M Saunte; J Boer; A Stratigos; J C Szepietowski; I Hamzavi; K H Kim; K Zarchi; C Antoniou; L Matusiak; H W Lim; M Williams; H H Kwon; M A Gürer; F Mammadova; A Kaminsky; E Prens; H H van der Zee; V Bettoli; S Zauli; J Hafner; S Lauchli; L E French; H Riad; M El-Domyati; H Abdel-Wahab; B Kirby; G Kelly; P Calderon; V del Marmol; F Benhadou; J Revuz; C C Zouboulis; I Karagiannidis; K Sartorius; L Hagströmer; E McMeniman; N Ong; M Dolenc-Voljc; Z B Mokos; L Borradori; R E Hunger; C Sladden; N Scheinfeld; N Moftah; L Emtestam; J Lapins; N Doss; I Kurokawa; G B E Jemec
Journal:  Br J Dermatol       Date:  2015-11-03       Impact factor: 9.302

Review 4.  Laser and light-based treatment options for hidradenitis suppurativa.

Authors:  Iltefat H Hamzavi; James L Griffith; Farhaad Riyaz; Schapoor Hessam; Falk G Bechara
Journal:  J Am Acad Dermatol       Date:  2015-11       Impact factor: 11.527

5.  Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation.

Authors:  Christos C Zouboulis; Veronique Del Marmol; Ulrich Mrowietz; Errol P Prens; Thrasivoulos Tzellos; Gregor B E Jemec
Journal:  Dermatology       Date:  2015-06-30       Impact factor: 5.366

6.  Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.

Authors:  Olivier Join-Lambert; Hélène Coignard; Jean-Philippe Jais; Hélène Guet-Revillet; Sylvain Poirée; Sylvie Fraitag; Vincent Jullien; Florence Ribadeau-Dumas; Jacques Thèze; Anne-Sophie Le Guern; Sylvie Behillil; Anne Leflèche; Patrick Berche; Paul Henri Consigny; Olivier Lortholary; Xavier Nassif; Aude Nassif
Journal:  Dermatology       Date:  2010-11-25       Impact factor: 5.366

7.  Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients.

Authors:  G Shalom; T Freud; I Harman-Boehm; I Polishchuk; A D Cohen
Journal:  Br J Dermatol       Date:  2015-06-11       Impact factor: 9.302

8.  European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.

Authors:  C C Zouboulis; N Desai; L Emtestam; R E Hunger; D Ioannides; I Juhász; J Lapins; L Matusiak; E P Prens; J Revuz; S Schneider-Burrus; J C Szepietowski; H H van der Zee; G B E Jemec
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-01-30       Impact factor: 6.166

9.  What causes hidradenitis suppurativa?

Authors:  H Kurzen; I Kurokawa; G B E Jemec; L Emtestam; K Sellheyer; E J Giamarellos-Bourboulis; I Nagy; F G Bechara; K Sartorius; J Lapins; D Krahl; P Altmeyer; J Revuz; C C Zouboulis
Journal:  Exp Dermatol       Date:  2008-05       Impact factor: 3.960

10.  Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.

Authors:  Olivier Join-Lambert; Hélène Coignard-Biehler; Jean-Philippe Jais; Maïa Delage; Hélène Guet-Revillet; Sylvain Poirée; Sabine Duchatelet; Vincent Jullien; Alain Hovnanian; Olivier Lortholary; Xavier Nassif; Aude Nassif
Journal:  J Antimicrob Chemother       Date:  2015-11-12       Impact factor: 5.790
View more
  1 in total

1.  Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.

Authors:  Claudia J Posso-De Los Rios; Akua Sarfo; Mondana Ghias; Raed Alhusayen; Iltefat Hamzavi; Michelle A Lowes; Afsaneh Alavi
Journal:  Exp Dermatol       Date:  2019-04-29       Impact factor: 3.960
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.